Category: Vaccines
Global Vaccines
-
Foot and Mouth Disease (FMD) Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 2022. Looking forward, IMARC Group expects the market to reach US$ 3,070.7 Million by 2028, exhibiting a growth rate (CAGR) of 7.2% during 2023-2028. The foot and mouth disease (FMD) occurs due to a transboundary, ... Read More
-
Biologic Therapeutics Market Forecasts to 2030 – Global Analysis By Product (Gene Therapy, Cell Therapy, Vaccines, Antibody Therapeutics and Other Products), Type, Application and By Geography
... is accounted for $457.56 billion in 2023 and is expected to reach $968.08 billion by 2030 growing at a CAGR of 11.3% during the forecast period. The pharmaceutical industry sector that concentrates on the development, ... Read More
-
Biopharmaceuticals Market Forecasts to 2030 – Global Analysis By Product Type (Monoclonal Antibodies, Interferon, Insulin, Growth and Coagulation Factor, Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Synthetic Immunomodulators, Recombinant Hormones, Recombinant Enzymes, Cell and Gene Therapies, Synthetic Immunomodulators and Other Product Types), Application and By Geography
... Gene Therapies, Synthetic Immunomodulators and Other Product Types), Application and By Geography According to Stratistics MRC, the Global Biopharmaceuticals Market is accounted for $1047.45 million in 2023 and is expected to reach $2686.05 million by ... Read More
-
Global Poultry and Livestock Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Poultry and Livestock Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Poultry and Livestock Vaccines. The report ... Read More
-
Seasonal Influenza Vaccines Epidemiology Analysis and Forecast to 2032
... and B cause human disease of public health concern (WHO, 2023). Influenza transmission occurs when people with the flu cough, sneeze, or talk, thereby disseminating droplets. These droplets can land in the mouths or noses ... Read More
-
Global Vaccines Market Outlook, 2028
... infectious diseases among the population of the affluent nations. World Health Organization (WHO) states that immunization awareness and government initiatives have helped prevent 2-3 million deaths annually. Greater investments coupled with merging and partnerships of ... Read More
-
Global Vaccines Market Overview, 2023-28
... a number of diseases, such as polio and smallpox, with high death rates. Vaccinations play a crucial role to maintain sustainable health of people across different countries; hence, they are employed in various regional disease-prevention ... Read More
-
Global Influenza Vaccine Market: Analysis by Valency (Quadrivalent & Trivalent), By Vaccine Type (Inactivated And Live Attenuated), By Technology (Egg-based & Cell-based), By Age Group (Adult & Pediatric), By Route Of Administration (Injection & Nasal Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028
... Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028 The influenza vaccine, often referred to as the flu ... Read More
-
Global Meningococcal Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Meningococcal Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Meningococcal Vaccines. The report also introduces players in the industry ... Read More
-
Malaria Treatment Global Market Report 2023 Including: 1) By Treatment: Prescription Medications; Vaccines; Diagnostic Tests 2) By Route of Administration: Oral; Parenteral; Intravenous 3) By Distribution Channel: Direct Tender; Hospital Pharmacies; Retail Pharmacies; Online Pharmacies 4) By End User: Hospitals; Specialty Clinics; Homecarers Covering: Pfizer Inc.; Merck & Co.; Johnson & Johnson; Roche Holding AG; Bayer AG
... User: Hospitals; Specialty Clinics; HomecarersCovering: Pfizer Inc.; Merck & Co.; Johnson & Johnson; Roche Holding AG; Bayer AG Malaria Treatment Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Travel Vaccines Global Market Report 2023 Including: 1) By Disease: Hepatitis A; Diphtheria, Pertussis, And Tetanus (DPT); Yellow Fever; Typhoid; Hepatitis B; Measles And Mumps; Rabies; Meningococcal; 2) By Composition: Mono Vaccines; Combination Vaccines 3) By Booking Channel: Online Booking; In-Person Booking 4) By Application: Domestic Travel; Outbound Travel Covering: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA
... Channel: Online Booking; In-Person Booking4) By Application: Domestic Travel; Outbound TravelCovering: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA Travel Vaccines Global Market Report 2023 from The Business Research Company ... Read More
-
Neoantigen Targeted Therapies Global Market Report 2023 Including: 1) By Type: Monotherapy; Combination Therapy 2) By Immunotherapy Type: DNA Or RNA-Based Vaccines; Protein-Based Vaccines; Dendritic Cell Vaccines; TIL-Based Therapies 3) By Target Disease Indication: Colorectal Cancer; Renal Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer 4) By Route of Administration: Intradermal; Intravenous; Subcutaneous 5) By Application: Medical Research Institution; Hospital; and Clinic Covering: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company
... Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer4) By Route of Administration: Intradermal; Intravenous; Subcutaneous5) By Application: Medical Research Institution; Hospital; and ClinicCovering: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers ... Read More
-
Influenza Vaccines Global Market Report 2023 Including: 1) By Vaccine Type: Inactivated; Live Attenuated 2) By Valency: Quadrivalent; Trivalent 3) By Route Of Administration: Injection; Nasal Spray 4) By Age Group: Pediatric; Adult 5) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply Covering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC.
... Pharmacies; Government And Institutional SupplyCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC. Influenza Vaccines Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Fill Finish Manufacturing Global Market Report 2023 Including: 1) By Product: Consumables; Instruments 2) By Modality: Recombinant Proteins; Monoclonal Antibodies; Vaccines; Cell Therapies; Viral Gene Therapies; Non-Viral Gene Therapies 3) By End-User: Contract Manufacturing Organizations; Biopharmaceutical Companiess Covering: Johnson And Johnson; AbbVie Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson And Company; Baxter International Inc.
... Johnson And Johnson; AbbVie Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson And Company; Baxter International Inc. Fill Finish Manufacturing Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with ... Read More
-
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) - Global Forecast to 2028
... projected to grow from USD 13.7 billion in 2023 to USD 18.0 billion by 2028 at a CAGR of 5.6%. The key factors driving the overall market growth include an increase in the number of ... Read More
-
Biotechnology Contract Manufacturing Market by Service (Manufacturing, Fill Finish, Packaging), Type (Drug Substance, Drug Product), Scale, Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecasts to 2028
... manufacturing market is estimated to reach USD 24.8 billion by 2028 from USD 16.6 billion in 2023, at a CAGR of 8.3% during the forecast period of 2023 to 2028. The growth of this market ... Read More
-
Global Toxoid Vaccine Market - 2023-2030
... period 2023-2030. Toxoid vaccines use toxoids (as antigens) to induce an immune response in protecting against diseases caused by toxins secreted by specific bacteria. Compared to other vaccines, toxoid vaccines are more stable and less ... Read More
-
Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing), Therapeutic Area (Oncology, Cardiology, Neurology), and Application (Vaccine, mAbs, CGT) - Global Forecast to 2028
... clinical trials market is projected to reach USD 73.2 billion by 2028 from USD 48.2 billion in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The growth of this ... Read More
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), Route of administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Type ( Human vaccine , Veterinary vaccine) - Global Forecast to 2028
... size is projected to reach USD 1.2 billion by 2028 from USD 0.8 billion in 2023, at a CAGR of 6.9% during the forecast period. Factors such as as the rising prevalence of infectious diseases, ... Read More
-
Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.61% during 2023-2028. Cancer is a malignant tumor caused by the uncontrollable growth of abnormal cells in the body. It can be treated ... Read More
-
Microcarrier Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... is a help matrix, which lets in the increase of adherent cells in bioreactors. In the large-scale business production of biologics and vaccines, microcarriers are employed to grow virus-generating or protein-producing adherent cellular populations. As ... Read More
-
Biologics Outsourcing Market Size - By Product (Antibodies, Recombinant Proteins, Vaccines), Service (Cell & Process Development, Analytical Testing), Source (Mammalian, Microorganism), Application, End-user, Global Forecast, 2023 - 2032
... expand at 14.1% CAGR from 2023-2032 driven by the increasing focus on R&D collaborations between biopharmaceutical companies and outsourcing partners. The rising complexities of biological drug development and production along with collaborative partnerships are enabling ... Read More
-
Global Therapeutic Vaccines Market, 2022-2035
... is worth highlighting that six out of ten individuals in the US are anticipated to be suffering from at least one chronic disease. Specifically, such patients are required to take medication on a daily basis, ... Read More
-
mRNA Therapeutics and Vaccines Market (2nd Edition), 2022-2035
... for protein synthesis are transferred from a strand of DNA to the ribosomes, where these instructions are translated and processed into functional proteins. Q1. How is the research and development (R&D) activity evolving in the ... Read More
-
Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Analysis By End User (Adult and Maternal & Pediatric), By Type (Vaccine & Antibody), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030
... up to 2030 RSV, or respiratory syncytial virus, is a common respiratory virus that causes mild, cold-like symptoms in both the upper and lower respiratory tracts. RSV can be harmful, especially in infants and the ... Read More
Research Assistance
